• Search
  • Advanced Search
Korean J Hepatol > Volume 13(4); 2007 > Article
5
The Korean Journal of Hepatology 2007;13(4): 571-575.
doi: https://doi.org/10.3350/kjhep.2007.13.4.571
Combined Hepatocellular-cholangiocarcinoma
Yoon Mi Jeen , So Young Jin
Department of Pathology, Soonchunhyang University Hospital, Seoul, Korea
KeyWords: Combined hepatocellular-cholangiocarcinoma; Carcinoma; Liver; Intermediate type; Hepatic progenitor cell; C-kit
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 3,880 View
  • 15 Download
Related articles

Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma2023 October;29(4)

Recent advances in the management of hepatocellular carcinoma2024 January;30(1)

Systemic therapy in advanced hepatocellular carcinoma2023 April;29(2)

Metabolic disease as a risk of hepatocellular carcinoma2021 January;27(1)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2253
TOTAL : 2236282
Close layer